Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.

Journal of the renin-angiotensin-aldosterone system : JRAAS - 1 Dec 2011

Orenes-Piñero Esteban, Hernández-Romero Diana, Jover Eva, Valdés Mariano, Lip Gregory Y H, Marín Francisco

Abstract excerpt

Hypertrophic cardiomyopathy (HCM) is a clinically heterogeneous autosomal dominant heart disease characterised by left ventricular hypertrophy in the absence of another cardiac or systemic disease that is capable of producing significant wall thickening. Microscopically it is characterised by cardiomyocyte hypertrophy, myofibrillar disarray and fibrosis. The phenotypic expression of HCM is multifactorial, with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy, Hypertrophic
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hypertrophy, Left Ventricular

Share to Polymorphism, Genetic

Share to Renin-Angiotensin System

Source

Identifiers

PMID: 21507890
DOI: 10.1177/1470320311405247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy.PMID 21507890Read ↗

Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.Semantic proximity Read ↗

Hypertrophic Cardiomyopathy: Genetic Foundations, Outcomes, Interconnections, and Their ModifiersSemantic proximity Read ↗

The role of genetic variants in angiotensin I converting enzyme, angiotensinogen and the angiotensin II type-1 receptor in the pathophysiology of heart muscle disease.Semantic proximity Read ↗

Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice.Semantic proximity Read ↗

Familial hypertrophic cardiomiopathy: molecular basis and genotype-phenotype correlations.Semantic proximity Read ↗

Genetic variation in angiotensin II type 2 receptor gene influences extent of left ventricular hypertrophy in hypertrophic cardiomyopathy independent of blood pressure.Semantic proximity Read ↗

[Hypertrophic cardiomyopathy: a genetically-carried heart disease].Semantic proximity Read ↗

Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Modifier genes for hypertrophic cardiomyopathy.Semantic proximity Read ↗

Genetic characterization and genotype-phenotype associations in a large cohort of patients with hypertrophic cardiomyopathy – An ancillary study of the Portuguese registry of hypertrophic cardiomyopathySemantic proximity Read ↗

Phenotypic diversity in hypertrophic cardiomyopathy.Semantic proximity Read ↗

Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.